Dietary fibres differentially impact on the production of phenolic acids from rutin in an in vitro fermentation model of the human gut microbiota by Havlik, Jaroslav et al.
 Nutrients 2020, 12, 1577; doi:10.3390/nu12061577 www.mdpi.com/journal/nutrients 
Article 
Dietary Fibres Differentially Impact on the 
Production of Phenolic Acids from Rutin in an In 
Vitro Fermentation Model of the Human Gut 
Microbiota 
Jaroslav Havlik 1, Vittoria Marinello 1, Andrew Gardyne 1, Min Hou 1, William Mullen 2,  
Douglas J. Morrison 3, Thomas Preston 3, Emilie Combet 1 and Christine A. Edwards 1,* 
1 Human Nutrition, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life 
Sciences, University of Glasgow, Glasgow G31 2ER, UK; havlik@af.czu.cz (J.H.); 
vittoria_marinello@live.co.uk (V.M.); andrew.gardyne@outlook.com (A.G.);  
min-hou710@hotmail.com (M.H.); Emilie.CombetAspray@glasgow.ac.uk (E.C.) 
2 Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, 
University of Glasgow, Glasgow G12 8QQ, UK; William.Mullen@glasgow.ac.uk 
3 Scottish Universities Environmental Research Centre, East Kilbride G75 0QF, UK; 
Douglas.Morrison@glasgow.ac.uk (D.J.M.); Tom.Preston@glasgow.ac.uk (T.P.) 
* Correspondence: Christine.Edwards@glasgow.ac.uk 
Received: 21 April 2020; Accepted: 26 May 2020; Published: 28 May 2020 
Abstract: Polyphenols are often ingested alongside dietary fibres. They are both catabolised by, and 
may influence, the intestinal microbiota; yet, interactions between them and the impact on their 
resultant microbial products are poorly understood. Dietary fibres (inulin, pectin, psyllium, 
pyrodextrin, wheat bran, cellulose—three doses) were fermented in vitro with human faeces (n = 
10) with and without rutin (20 µg/mL), a common dietary flavonol glycoside. Twenty-eight phenolic 
metabolites and short chain fatty acids (SCFA) were measured over 24 h. Several phenolic 
metabolites were produced during fibre fermentation, without rutin. With rutin, 3,4-
dihydroxyphenylacetic acid (3,4diOHPAA), 3-hydroxyphenylacetic acid (3OHPAA), 3-(3 
hydroxyphenyl)propionic acid (3OHPPA) and 3-(3,4-dihydroxyphenyl)propionic acid 
(3,4diOHPPA; DOPAC) were produced, with 3,4diOHPAA the most abundant, confirmed by 
fermentation of 13C labelled quercetin. The addition of inulin, wheat bran or pyrodextrin increased 
3,4diOHPAA 2 2.5-fold over 24 h (p < 0.05). Rutin affected SCFA production, but this depended on 
fibre, fibre concentration and timepoint. With inulin, rutin increased pH at 6 h from 4.9 to 5.6 (p = 
0.01) but increased propionic, butyric and isovaleric acid (1.9, 1.6 and 5-fold, p < 0.05 at 24 h). 
Interactions between fibre and phenolics modify production of phenolic acids and SCFA and may 
be key in enhancing health benefits. 
Keywords: colonic metabolism; flavonols; gas chromatography mass spectrometry; gut 
microbiome; phenolic acids: dietary fibre 
 
1. Introduction 
Intake of plant phenolics is estimated to be ~1 g per day [1–3] in most populations, a small 
proportion of which are flavonols [3,4]. Daily flavonol intake varies between populations and dietary 
intake patterns: from ~5.4 mg per day in Finland [5], 19 mg per day Spain [6] and 34 mg per day in 
France [1], with 59%–79% of daily flavonol intake represented by quercetin glycosides [1,6]. Rutin is 
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an abundant glycosidic form of quercetin, found in significant quantities in capers, black olives and 
buckwheat (332, 45 and 36 mg/100 g fresh food weight, respectively) [7]. Drupe fruits such as 
blackcurrants and raspberries may also provide up to 11 mg of rutin per 100 g [7,8]. Research on 
flavonols as plant food bioactives with proposed health benefits has expanded in the last two 
decades, with major focus on cancers and cardiovascular diseases [9–12]. 
The metabolism of rutin has been extensively studied ex vivo [13–15], in rodents [16–18] and in 
human intervention studies: after ingestion, only 14%–17% of rutin is absorbed in the small intestine 
[19,20]. Most ingested rutin therefore enters the colon, where it is catabolised by the gut microbiota 
via a pathway starting with the hydrolytic cleavage of the disaccharide moiety [19–21]. This, 
combined with fission of the C-ring of the aglycone, results in the formation of a series of phenolic 
acids and phloroglucinol derivatives from either of the two remaining rings [15]. There is a high 
degree of inter-individual variability in the metabolites produced [15,21], with age [21] and ethnicity 
[22], two factors shown to modify the metabolite fingerprint excreted in urine. Although 
3,4diOHPAA is usually the dominant early metabolite, some individuals appear to shift metabolism 
towards different phenolic products [15]. Phenolic acids are absorbed from the colon and released 
into the circulation alongside other metabolites and are therefore speculated to be responsible for 
some of the biological effects of rutin [15,23]. The main metabolite, 3,4diOHPAA, has been shown to 
possess high biological activities in vitro with some advantages over its parent compound, such as 
low toxicity and solubility [24], antiplatelet aggregation properties [25], suppression of 
lipopolysaccharide induced pro-inflammatory cytokines TNF-α, IL-1β and IL-6 in peripheral blood 
mononuclear cells [26] and inhibition of protein glycation [23,27]. 
Much of the evidence for gut-microbiota-mediated metabolism of polyphenols to date has been 
assessed using in vitro batch cultures with human stool samples. The studies differ in media used. 
Some cultures did not contain any fermentable carbohydrates [13,15,28,29], while others did [14,30]. 
The presence of fermentable carbohydrates in media, however, might be an important factor 
changing the pattern of polyphenol catabolism, yet the results are contrasting. More rapid 
fermentation of rutin was seen in the presence of glucose [15] resulting in greater production of 
metabolites, while less total phenolic acids and 3,4diOHPAA were seen in the presence of complex 
carbohydrates in the medium [31]. There are several potential mechanisms by which additional 
fermentable carbohydrate impacts upon bacterial polyphenol catabolism. Firstly, fermentation of 
carbohydrates to short chain fatty acids (SCFA) results in a decrease in colonic pH [32] promoting 
changes in bacterial enzyme activity [33]. Secondly, some fibres may be selective in promoting growth 
of specific bacterial groups within the intestinal microbiota [34], thus altering polyphenol 
metabolism. Thirdly, dietary fibres could decrease or delay colonic polyphenol availability by 
altering small intestinal absorption and transit time [35]. Finally, dietary fibre may be a rich source of 
non-extractable polyphenols and release associated metabolites when they are fermented by the 
bacteria [36], which trigger antimicrobial action or inhibit bacterial hydrolases. 
The evidence suggests that the polyphenol metabolites produced by the gut microbiota change 
(in terms of quality and quantity) in the presence of fibre. In this study, we undertook a systematic 
investigation of the impact of dietary fibres (pectin, inulin, psyllium, pyrodextrin, wheat bran and 
cellulose) on the catabolism of rutin in human faecal batch cultures, to inform food product 
formulation (e.g., soups, juices), towards improved products with higher health impact. 
2. Materials and Methods 
2.1. Chemicals 
Oxygen free nitrogen (OFN) was from BOC-Linde (UK). Chemicals used as standards 
(Supplementary materials, Table S1), 3-(3-hydroxyphenyl)propionic acid [3,3OHPPA], 3-3,4-
dihydroxyphenyl)propionic acid [3,3,4diOHPPA], 4-hydroxy 3-methoxyphenylacetic acid 
[4OH3MPAA] and 4-hydroxymandelic acid [4OH-mandelic acid] were from Alfa Aesar (Thermo 
Fisher Scientific, MA, US), 2,4,5-trimethoxycinnamic acid [TMCA], 3-(3-hydroxy 4-
methoxyphenyl)propionic acid [3,3OH4MPPA], 3-(4-hydroxy 3-methoxyphenyl)propionic acid 
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[3,4OH3MPPA], 3-(4-hydroxyphenyl)propionic acid [3,4OHPPA], 3,4-dihydroxybenzoic acid 
[3,4OHBA], 3,4-dihydroxyphenylacetic acid [3,4DiOHPAA], 3-hydroxy-4-methoxycinnamic acid 
[isoferulic acid], 3-hydroxy-4-methoxyphenylacetic acid [3OH4MPAA], 3-hydroxybenzoic acid 
[3OHBA], 3-hydroxyphenylacetic acid [3OHPAA], phenylacetic acid [PAA], 3-phenyllactic [3PLA], 
3-phenylpropionic acid [3PPA], 4-hydroxy 3-methoxybenzoic acid [VAN], 4-hydroxybenzoic acid 
[4OHBA], 4-hydroxyphenyl acetic acid [4OHPAA], benzoic acid [BA], caffeic acid, ferulic acid, 
mandelic acid, p-coumaric acid, phloroglucinol, pyrocatechol, quercetin, resorcinol and trans-
cinnamic acid were purchased from Sigma Aldrich. The uniformly labelled 13C quercetin (>98.5% C 
atom labelled) was obtained from Isolife (NL). The fibres used in the study were as follows: inulin 
HP ([INU]; Beneo-Orafti, BE), pectin [PEC] from citrus peel and α-cellulose ([CEL]; Sigma Aldrich), 
wheat bran Organic ([WB]; Infinity Foods, UK), powdered psyllium husks ([ISP]; Myprotein, UK), 
pyrodextrin or else resistant maltodextrin [RM] was Fibersol-2 (Matsutani Chemical Industry, JP). 
Other solvents, buffer constituents, and reagents were from Sigma-Aldrich and were of highest 
available purity. 
2.2. In Vitro Fermentation Model 
2.2.1. Donors, Sampling and Faecal Slurry Preparation 
Faecal samples were obtained from healthy donors aged 20 to 41 years (mean age 27), with a 
mean BMI 26.3 kg/m2 (ranging 22.8–35.1). Donors were mostly male (72%), all Caucasian, had not 
undergone antibiotic treatment in the previous 6 months, had no history of gastrointestinal disease, 
and were not vegetarian or vegan. All subjects followed a low polyphenol-low fibre diet (for details, 
see Supplementary Materials, Figure S3) for 48 h before providing a faecal sample. The study was 
approved by the College of Medical, Veterinary and Life Sciences Ethics Committee, University of 
Glasgow (no. 2011023) and donors gave written informed consent. 
Stool samples were collected using in-house collection kits consisting of a sealed 0.7 L plastic 
container sealed within a plastic bag with the addition AnaeroGen™ 3.5 L Sachet (Oxoid, UK) after 
sample collection. The samples were processed in the laboratory within 2 h of sampling. A faecal 
slurry (25% wt/wt) was prepared by mixing 50 g of faeces with 150 mL of sterile OFN-purged 
phosphate buffer, pH 7.0 using a blender and the particulate material was removed by straining 
through nylon mesh. 
2.2.2. Fibres 
Fibres were pre-weighed (0.8, 1.7 and 3.3 g) into 100 mL gas-tight, crimp-top sealed fermentation 
bottles, to represent assay concentrations corresponding to a physiologically representative bolus 
intake of 5, 10 and 20 g of fibre potentially diluted in 300 mL of colonic contents [37]. INU, WB, RM 
and CEL were tested at all three concentrations. Only fermentations containing 0.8 and 1.7 g fibre 
were used for PEC and just 0.8 g for ISP due to the high viscosity. Vials containing no fibre were also 
included (no fibre blanks). The fermentations were carried out with and without rutin to account for 
any phenolics intrinsically present in the fibres. 
2.2.3. Faecal Incubations 
Each vial contained 42 mL of fermentation medium at pH 7.0, 2 mL of reducing solution and 1 
mL of rutin aqueous solution (1 mg/mL) or water for blanks [38]. In some cases, the size of the 
fermentation model was scaled-down by half due to low donor faecal sample weight. The rutin 
concentration used in the fermentations in this study was selected based on 86% rutin recovery in 
ileostomy subjects [19] assuming a postprandial ileal output of 162 mL within 2 h after consuming a 
300 mL meal [39] and additional estimated two-fold dilution in the proximal colon by colonic 
secretions. Under these conditions, a moderate intake of fruit, e.g., 200 g of blackberries containing 
3.89 mg/100 g [8] may result in approximately 20 µg/mL of rutin in the proximal colon. 
After full decolouration of the medium, we inoculated with 5 mL of faecal slurry (total volume 
50 mL) and incubated in a shaking bath at 37 °C, 60 strokes/min and sampled at 0 h, 6 h and 24 h. 
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Aliquots (5 × 1 mL) were collected with a syringe and needle through the self-sealing septa at each 
timepoint and stored at –80 °C. One aliquot was used for pH determination with a calibrated pH 
meter (Hannah pH20 instruments, USA). Aliquots for SCFA analysis were alkalized to pH > 9 prior 
to storage [38,40]. 
2.2.4. 13C Labelled Quercetin Study 
13C quercetin (10 µg/mL) was fermented in parallel with native quercetin (12C) and 
corresponding controls. No fibre was added. The experiment was carried out as two independent 
replicates with the stool of a single donor donated within 1 month. The conditions were the same as 
above apart from being scaled-down to 1.5 mL of the fermentation fluid in each of the 5 mL vials. 
Quercetin (5 mg/mL, 3 µL in 100% methanol, 10 µg/mL in the assay) was injected into the incubation 
vials with a glass syringe. At each timepoint (0 h, 3 h, 6 h and 24 h), vials were taken and frozen at –
80 °C. Blank cultures not containing quercetin and samples containing quercetin but not stool 
inoculum (labelled as INI for timepoint 0 h) were prepared in parallel. They were thawed just before 
extraction and spun at 6000× g to remove particulate material from the supernatant. 
2.3. Fibre-Phenolic Sequestration Experiment 
To investigate the effect of fibres on recovery of phenolics from fermentation samples, fibres 
were pre-weighed in 5 mL tubes in amounts of 8, 17 and 33 µg and subsequently hydrated with 500 
µL of distilled water (pH 5.5), so that the final concentration corresponded to equivalent of 0.8, 1.7 
and 3.3 g/50 mL After spiking with mixed standards, (5 µg each), solutions were incubated for 6 h at 
37 °C and extracted using the same procedure as for fermentation samples. 
2.4. Phenolic Acids Extraction 
A gas chromatography-mass spectrometry (GC/MS) analysis of phenolic compounds in 
fermentation fluid was performed as previously described [41] with modifications. Fermentation 
aliquots were thawed and volumes of 500 µL transferred to 5 mL glass tubes. Internal standard 
solution (ISTD; 30 µL of 0.2 mg/mL 2,4,5-trimethoxycinnamic acid) was added, the mixture vortexed, 
acidified with 60 µL of 1M HCl, vortexed again, and left at 4 °C for 10 min. The mixture was then 
extracted twice with 1.5 mL of ethyl acetate. After each extraction step, the upper organic layer was 
removed after centrifugation at 1600 × g and transferred to 1.5 mL amber vials. Samples were 
evaporated at 45 °C until dryness (approx. 40 min) on Savant SpeedVac SPD131DDA concentrator 
(Thermo Fisher Scientific, MA, US), with repetitive extractions being pooled in the same 
corresponding vial. After the second evaporation, vial walls were rinsed with 200 µL of 
dichloromethane and evaporated again for 10 min. Dry residues were derivatised under OFN, using 
50 µL of N,O-Bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% chlorotrimethylsilane (TMCS) 
for 4 h at 65 °C. 
2.5. Phenolic Acid Analysis 
Anhydrous hexane (99%, 400 µL) was added to each vial before analysis. A set of 13 calibration 
solutions, containing 28 phenolic acids, hydroxybenzenes and quercetin ranging from 1 µg to 80 
µg/mL, was extracted and analysed alongside all faecal samples. The analysis was performed on a 
Trace GC equipped with a split/splitless injector interfaced to a DSQ mass spectrometer and an 
AI3000 autosampler (Thermo Fisher Scientific, MA, US) using the following conditions: inlet 
temperature 250 °C, split injection (1:25), 1 µL sample volume. A ZebronTM ZB-5 capillary column (30 
m × 0.25 mm i.d., df = 0.25 µm) was used for separation. The carrier gas flow (He) was constant at 1.2 
mL/min. The oven programme started at 140 °C (held 0.5 min), rose to 160 °C at 6 °C/min to 270 °C 
and was increased then at 30 °C/min to a final temperature of 320 °C (held for 4 min). The transfer 
line was maintained at 310 °C and ion source temperature at 270 °C. Acquisition was performed in 
positive electron ionization mode in full scan (m/z 50–450) with an ionization energy of 70 eV, from 
1.7 to 20 min. Quercetin and 13C-quercetin were monitored using single ion monitoring (SIM) for ion 
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m/z 647, 662 and 595 respectively, from 21–25 min. Identification of phenolics and quercetin was 
achieved by comparison with the retention times and mass spectra of authentic standards. 
Acquisition and analyses of GC-MS data were performed on Xcalibur version 2.1 (Thermo Fisher 
Scientific, MA, US). The 13C-quercetin and its products were quantified using calibration curves based 
on quantifier ions of the corresponding non-labelled compounds in MS Excel. Differences between 
controls and treatments were thoroughly checked for unknown metabolites using AMDIS ver. 2.1, 
Compare Files Postanalysis feature. A detailed GC-MS method including conditions and basic 
validation is shown in Supplementary Materials, Table S2. 
2.6. Short Chain Fatty Acid Extraction and Analysis 
Short chain fatty acids (SCFA) were measured by GC-FID of acidified ether extracts of the 
fermentation fluid as previously described [31]. 
2.7. Statistical Analysis 
Data were expressed as mean values and visualised in IBM SPSS Statistics ver. 22 (International 
Business Machines, NY, US). Normality was assessed using the Shapiro-Wilk test. Due to non-normal 
distribution in some subsets, skewness was reduced by log10 transformation. Potential differences 
between controls and treatments were analysed using 3-way repeated measures analysis of 
covariance (MANOVA), one-way ANOVA with Dunnett’s or Tukey’s post hoc test for factors fibre 
(INU, PEC, ISP, RM, WB, CEL), concentration (0, 0.8, 3.3 g/50 mL of fibre), rutin (including rutin, R+; 
excluding rutin R-) or Time (0 h, 6 h, 24 h) on the 28 phenolic metabolites used as variables as 
indicated in the method section. 
Areas under 24 h curve (AUC24) were established for compounds of interest, reflecting their total 
production in solution. If the solution initially contains 10 µg/mL of a compound which remains 
unmetabolised over time, the AUC24 value will be 240 µg/mL/24 h; analogously, if same compound 
is linearly metabolised to 0 within 24 h, it produces an AUC24 of 120 µg/mL/24 h. 
The effects of rutin on SCFA and pH were analysed using independent samples t-test (2-tailed) 
for each factor with a Benjamini-Hochberg multiple testing correction. No data transformation was 
applied. Levene’s test was used to assess equality of variances. Results were expressed as means ± 
S.E.M or S.D. and were considered significant at p < 0.05. 
3. Results 
3.1. GC-MS Method Optimisation and Validation 
The method was adapted from [42] and internally validated. Recoveries were determined by 
spiking a pooled faecal sample with phenolic acid standards at concentrations of 10 µg/mL. Average 
recoveries were 91%, typically ranging between 81% and 106%, however, for 4OH-mandelic acid, BA, 
3PPA, PAA and the polar hydroxybenzenes, such as resorcinol or phloroglucinol recoveries were low 
(10%–26%). Limits of detection (signal-to-noise ratio of 3:1) for four main rutin metabolites: 3OHPAA, 
3,3OHPPA, 3,4diOHPAA and 3,3,4diOHPPA were 0.2, 0.15, 0.08 and 0.25 µg/mL, respectively. Basic 
method validation data are shown in Supplementary Materials, Table S2. 
3.2. Phenolics and Their Metabolites Released from Fibres 
Fibres alone, even without addition of rutin released significant amounts of phenolics, which 
showed fibre-specific patterns (Figure 1, Table 1). 
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Figure 1. Relative profile of phenolic metabolites (rel% AUC24) released from fibres present in the 
medium in fermentation vials with rutin added (R+, 20 µg/mL) and without rutin (R-); INU, inulin, 
PEC, pectin, ISP, psyllium, RM, pyrodextrin, WB, wheat bran, CEL, cellulose; n = 10. The light pink 
bar refers to the main metabolite of rutin and shows its rather low proportion in the whole pool of 
phenolic acid metabolites present. For other abbreviations, see Materials and Methods section. 
Table 1. Area under the curve (AUC24) of phenolics found in fermentation slurries with fibres only 
(rutin not added) at 0.8 g/50 mL, AUC24 µg/mL/24 h. 
 
Fibre 
PEC INU ISP RM # WB CEL Blank ## 
Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM 
BA 37.1 ± 4.4 49.7 ± 6.6 37.7 ± 5.3 * 78.4 ± 15.7 48.0 ± 4.6 35.1 ± 6.1 33.3 ± 3.7 
PAA 245.6 ± 20.9 ** 205.1 ± 15.4 ** 267.3 ± 19.1 ** 233.2 ± 16.7 ** 649.4 ± 53.6 510.7 ± 37.8 598.5 ± 40.9 
Pyrocatechol 20.6 ± 4.5 58.7 ± 8.6* 16.8 ± 3.2 43.3 ± 2.9 ** 38.3 ± 5.4 ** 23.4 ± 5.2 15.3 ± 3.8 
Resorcinol 8.0 ± 2.7 6.2 ± 2.5 7.2 ± 2.6 0.0 ± 0.0 9.2 ± 2.6 6.4 ± 2.2 5.1± 1.8 
3PPA 191.6 ± 21.6 139.6 ± 16.5 136.3 ± 11.8 129.3 ± 5.0 280.6 ± 32.8 139.6 ± 16.6 118.3 ± 12.4 
Mandelic acid 5.3 ± 1.4 4.4 ± 1.2 10.3 ± 1.8 ** 1.4 ± 0.6 10.4 ± 1.8 * 3.1 ± 0.8 2.5 ± 0.6 
Cinnamic acid 4.6 ± 1.7 * 2.8 ± 1.4 2.2 ± 1.3 0.0 ± 0.0 2.3 ± 1.2 1.8 ± 1.0 1.9 ± 1.0 
3HBA 3.2 ± 1.5 * 6.6 ± 3.3 6.3 ± 3.0 10.7 ± 2.3 5.9 ± 3.0 3.7 ± 1.6 3.9 ± 2.0 
3-Phenyllactic acid 34.5 ± 6.6 120.6 ± 15.5 ** 11.9 ± 5.1 22.1 ± 9.9 7.2 ± 1.7 2.4 ± 0.6 4.6 ± 1.5 
3OHPAA 7.0 ± 1.2 7.1 ± 1.3 10.7 ± 1.4 8.9 ± 2.4 7.6 ± 1.2 6.7 ± 1.2 4.5 ± 0.8 
4OHBA 3.7 ± 0.6 4.9 ± 1.0 6.8 ± 0.8 10.4 ± 1.8 * 12.8 ± 1.1 ** 6.1 ± 1.2 2.8 ± 0.6 
Phloroglucinol 3.8 ± 1.3 10.9 ± 3.1 7.3 ± 2.0 6.4 ± 2.8 7.1 ± 2.1 6.4 ± 2.1 7.9 ± 1.8 
4OHPAA 14.1 ± 1.4 ** 16.8 ± 2.3 ** 12.4 ± 1.5 ** 14.3 ± 3.1 ** 62.4 ± 4.1 52.2 ± 3.7 50.0 ± 4.0 
3,3OHPPA 115.3 ± 8.5 ** 26.2 ± 3.9 ** 37.3 ± 4.7 11.6 ± 3.4 ** 128.5 ± 17.7 ** 36.3 ± 4.3 40.9 ± 6.8 
VAN + iso-VAN 0.9 ± 0.3 1.2 ± 0.3 3.1 ± 0.6 2.4 ± 1.0 7.3 ± 0.7 * 1.2 ± 0.3 0.8 ± 0.2 
4-OHmandelic acid 2.6 ± 1.2 2.9 ± 1.1 1.6 ± 0.7 0.0 ± 0.0 1.8 ± 0.7 3.2 ± 1.0 0.6 ± 0.1 
3OH4MPAA + 4OH3MPAA 7.2 ± 2.3 5.2 ± 1.5 7.1 ± 2.6 15.5 ± 6.9 11.1 ± 2.9 11.6 ± 4.3 6.1 ± 2.6 
3,4OHPPA 23.2 ± 3.4 16.9 ± 3.5 18.5 ± 3.6 14.1 ± 4.8 26.0 ± 3.7 32.3 ± 5.9 27.6 ± 5.5 
3,4diOHBA 1.0 ± 0.2 2.3 ± 0.4 1.5 ± 0.2 3.3 ± 0.5 ** 5.3 ± 0.5 ** 1.0 ± 0.3 3.1 ± 1.5 
3,4diOHPAA 2.5 ± 0.5 1.3 ± 0.4 4.3 ± 0.6 ** 0.4 ± 0.2 2.8 ± 0.5 1.2 ± 0.3 4.0 ± 1.0 
3,3OH4MPPA 132.5 ± 12.0 ** 0.5 ± 0.1 ** 0.6 ± 0.2 0.0 ± 0.0 0.4 ± 0.2 0.4 ± 0.2 5.0 ± 2.1 
3,4OH3MPPA 2.1 ± 0.6 1.5 ± 0.6 1.8 ± 0.9 ** 0.0 ± 0.0 ** 26.3 ± 3.2 ** 2.1 ± 0.6 1.0 ± 0.4 
3,3,4diOHPPA 12.2 ± 3.7 4.0 ± 2.0 8.9 ± 2.6 2.2 ± 1.0 9.6 ± 1.6 ** 6.2 ± 2.3 5.8 ± 1.8 
p-Coumaric acid 0.2 ± 0.1 0.3 ± 0.1 0.4 ± 0.1 0.0 ± 0.0 0.5 ± 0.1 0.1 ± 0.0 0.4 ± 0.1 
3OH4M Cinnamic acid 0.5 ± 0.3 0.1 ± 0.1 0.4 ± 0.1 0.0 ± 0.0 0.5 ± 0.2 0.0 ± 0.0 0.1 ± 0.1 
Ferulic acid 0.2 ± 0.1 0.2 ± 0.1 0.6 ± 0.2 0.0 ± 0.0 5.2 ± 0.7 ** 0.4 ± 0.1 0.6 ± 0.2 
Caffeic acid 4.6 ± 2.0 4.2 ± 2.1 5.7 ± 1.9 0.8 ± 0.4 3.6 ± 1.0 2.9 ± 1.0 2.7 ± 1.3 
Quercetin 6.0 ± 3.3 7.0 ± 3.8 11.7 ± 2.9 ** 0.0 ± 0.0 7.8 ± 3.2 3.0 ± 1.6 4.4 ± 1.8 
* significantly different at p < 0.05 from CEL; ** significantly different at p < 0.01 from CEL using 
multivariate ANOVA with Dunnett’s post hoc test; n = 10 except (#, n = 2, ##, n = 17); S.E.M, standard 
error of mean; values in bold refer to a significant increase of the analyte in comparison to the blank; 
INU, inulin, PEC, pectin, ISP, psyllium, RM, pyrodextrin, WB, wheat bran, CEL, cellulose. 
Some of these (pyrocatechol; BA; PAA; 3PPA; 3,3OHPPA; 3,3,4diOHPPA or 3,3OH4MPPA) are 
potential rutin catabolites. In fermentations blank or CEL (no matter if rutin was present or not), 
phenolic profile was similarly represented by high AUC24 for PAA (510–600 µg/mL/24 h) and 3PPA 
Nutrients 2020, 12, 1577 7 of 17 
 
(118–140 µg/mL/24 h) (Figure 1, Table 1). The presence of fermentable carbohydrates except WB 
decreased PAA 2-fold, and increased selected phenolics in fibre-specific manner, e.g., 3PLA was 
highest in fermentations of INU and 3,3OHPPA and 3,3H4MPPA were more abundant when PEC 
was fermented. None of the fibres released 3,4diOHPAA – (the main rutin metabolite) in significant 
quantities except ISP which contained also very small significant amounts of quercetin (Table 1). 
3.3. Fibre-Phenolics Sequestration Interactions 
When spiking the fibre suspensions in aqueous solution (pH 5.0) with 5 µg of standards, we 
observed ~160% recoveries for all metabolites in the presence of PEC, as a consequence of ISTD 
sequestration. Recoveries of the four potential rutin metabolites (3OHPPA, 3,4diOHPAA, 
3,3,4diOHPPA) except 3,3OHPAA, were significantly lower in the presence of WB than that of BLA. 
WB also highly reduced the recovery of non-rutin metabolites mandelic acid, caffeic acid, p-coumaric 
acid but more importantly that of quercetin and moderately that of 4OHPAA, both potential rutin 
metabolites (for details, see Supplementary Materials, Table S3). At the highest concentration of WB, 
the majority of these compounds were trapped in the matrix, resulting in poor < 4% recoveries. The 
most prominent effect of WB was seen on 3,4diOHPAA and quercetin, even the lowest concentration 
present in the sample reduced their recoveries to 8 and 13%, respectively. However, other fibres did 
not interfere with the recovery of the spiked standards and these were 98%–107% compared to 
recoveries from blank samples (Supplementary Materials, Table S3). 
3.4. Colonic Catabolism of Rutin in a Human Batch Fermentation Model 
When no fibre was present in fermentations, rutin was catabolised to a limited set of products: 
quercetin, 3,4diOHPAA, 3OHPAA, 3,3OHPPA and traces of 3,3,4diOHPPA. The sum of the 
metabolites explained 52%, 23% and 21% of the original molecular mass of the quercetin aglycone at 
0, 6 and 24 h, respectively. Some of the catabolites were also found in incubations without rutin. The 
data are shown in Figure 2A. To reveal the origin of these, the isotope-labelled experiment with 13C-
quercetin was conducted and has shown, that approximately 40% of the phenolic acids observed in 
fermentations do not originate from the added compound but are formed from other substrates. 
While 100% of 3,4diOHPAA was carrying the label, 75% of 3OHPAA was labelled alongside 25% 
unlabelled at both timepoints. Of the 3,3OHPPA only 17%–25% of the metabolite found was labelled 
alongside the majority of unlabelled compound (Figure 2B). Only a small proportion (0.1%) of 
labelled 3,3,4diOHPPA was found alongside the omnipresent unlabelled 3,3,4diOHPPA (not shown 
in the graph). Most of the 3,3OHPPA but also a large proportion of 3OHPAA are thus formed from 
precursors present in medium. The mean sum of 13C products for all fermentation timepoints was 
5.38, 3.79 and 5.57 µg/mL of the 10 µg/mL added at 3 h, 6 h and 24 h, respectively. No other 13C 
products were found. 
Nutrients 2020, 12, 1577 8 of 17 
 
 
Figure 2. (A) Catabolic products of rutin in fermentations without fibres. R+, fermentation with rutin, 
R-, corresponding control without rutin; (B) Catabolic products of rutin aglycone –quercetin. CON, 
without inoculum and quercetin, Q, quercetin, 13Q, 13C all-labelled quercetin isotope. Error bars 
denote S.E.M., n = 10 (for A), n = 4 (for B). INI, initial concentration added to vials (measured in a 
parallel sample without faecal inoculum). 
3.5. Effects of Fibres on Rutin Metabolites 
Despite the previous observations that rutin formed only a limited set of metabolites in 
fermentations without fibres, we investigated its effect on the whole profile of phenolic acids using a 
three-way MANOVA with fibre, concentration and rutin addition as factors. The between-subjects 
effects indicated a significant effect (p < 0.05) on six phenolic metabolites: mandelic acid, F(12,1174) = 
2.7, p = 0.001, vanillic+iso-vanillic acid, F(12,1174) = 3.258, p = 0.001; 3,4diOHPAA, F(12,1174) = 2.22, p 
= 0.009; 3,3,4diOHPPA F(12,1174) = 2.01, p = 0.020 and p-coumaric acid, F(12,1174) = 4.529, p = 0.001. 
The significant interaction for 3,4diOHPAA was investigated by simpler interaction analysis using 
independent samples t-test (2-tailed) between no fibre added and each fibre concentrations, 
separately for each timepoint. 
WB significantly increased the concentration of 3,4diOHPAA at 24 h, p = 0.006 compared to no 
fibre, with an 2.3-fold increase between blank and the highest concentration tested and INU presence 
at 24 h facilitated a 2.5-fold increase between blank and the highest concentration p = 0.018 and a 2.3-
fold increase for the concentration 1.7 g/50 mL (p = 0.056) (Figure 3). 
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Figure 3. Concentration of 3,4diOHPAA in fermentations in the presence of fibres at four 
concentrations (0, 0.8, 1.7 and 3.3 g/50 mL) in fermentations with rutin (R+; 20 µg/mL) and without 
rutin (R-); INU, inulin, PEC, pectin, ISP, ispaghula, RM, pyrodextrin, WB, wheat bran, CEL, cellulose; 
means ± S.E.M; independent samples t-test (2-tailed), n = 10. 
Additionally, there was a 1.6-fold increase for RM at the highest concentration (p = 0.066). 
Plotting the data of individual donors highlighted non-producers of the metabolite (4 of 10), 
producers (6 of 10 subjects, of which donors 1, 2, 3, 4 and 5 or 50% responded to the addition of fibre 
with an increased production of 3,4diOHPAA) (Supplementary Materials, Figure S1). The same t-test 
applied to AUC24 data was not significant for any fibre, however the trend for AUC24 was similar 
(Figure 4). 
 
Figure 4. Area under the curve over 24 h of main metabolite 3,4diOHPAA in fermentations with rutin 
added (R+, 20 µg/mL) and without rutin (R-) as influenced by presence of fibre at four concentrations 
(0, 0.8, 1.7 and 3.3 g/50 mL); INU, inulin, PEC, pectin, ISP, psyllium, RM, pyrodextrin, WB, wheat 
bran, CEL, cellulose; means ± S.E.M. 
3.6. Impact of Fibres and Rutin on pH and SCFA Production 
The addition of rutin had a small influence on pH and SCFA profiles and this effect was fibre-
specific. In order to provide a generalised and clear message of the influence of fibre in fermentations 
with the presence of absence of rutin, we carried out an independent samples t-test on AUC24 values 
for SCFA across all fibres and concentrations. The presence of rutin clearly increased propionic acid 
by 19% (p < 0.001), decreased isobutyric acid from 92.4 mmol/L/24 h to 3.8 mmol/L/24 h (p < 0.001), 
increased butyric acid by 12% (p = 0.032), valeric acid by 21% (p < 0.001) and caproic acid by 44% (p = 
0.005), for full results, see Table 2. 
Table 2. Effect of rutin on short chain fatty acid profile expressed as AUC24 irrespective of 
concentrations and type of fibre (ISP at concentration 0.8 g/50 mL, PEC at 0.8 and 1.7 g/50 mL, CEL, 
INU, RM at 0.8, 1.7 and 3.3 g/50 mL). 
AUC24 
Rutin not Added Rutin Added 
P-Value n (Total) 
Mean ± S.D. Mean ± S.D. 
pH 147.11 ± 19.42 148.68 ± 19.59 0.187 300 
C2 617.79 ± 351.04 618.37 ± 348.00 0.980 300 
C3 120.48 ± 66.61 143.05 ± 88.11 0.000 300 
IC4 92.24 ± 344.67 3.83 ± 3.83 0.000 300 
C4 202.45 ± 167.81 226.58 ± 177.94 0.032 300 
IC5 6.80 ± 6.57 6.87 ± 6.45 0.874 300 
C5 11.80 ± 8.15 14.35 ± 8.22 0.000 300 
IC6 0.01 ± 0.13 0.01 ± 0.11 0.574 300 
C6 2.50 ± 5.21 3.61 ± 6.64 0.005 300 
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C7 0.12 ± 0.62 0.16 ± 0.67 0.361 300 
Sum C2-C5 1051.56 ± 578.89 1013.04 ± 516.17 0.285 300 
Independent samples t-test (2-tailed) was used. For abbreviations and AUC24 explained, see Materials 
and methods section. Values except pH are expressed in mmol/L/24 h. Statistically significant values 
(p < 0.05) are in bold. 
The effect of rutin presence on SCFA fermentation profiles can be demonstrated in the case of 
INU (Figure 5). Rutin presence increased pH at timepoint 6 h (for 0.8 g/50 mL the pH changed from 
pH 4.94 to pH 5.63 (p = 0.010) and a similar, though not significant effect, was seen for other fibre 
concentrations. 
 
Figure 5. Effect of rutin on formation short chain fatty acid from inulin (3 concentrations) in faecal 
incubations; * significantly different (p < 0.05), ** (p < 0.01) between fermentation with rutin (red) and 
without rutin (blue) using independent samples t-test, adjusted for multiple comparisons, means ± 
SD for n = 10; C2, acetic acid, C3, propionic acid, C4, butyric acid, IC4, isobutyric acid, C5, valeric acid, 
IC5, isovaleric acid. 
There was no effect on acetic acid, but propionic acid was increased significantly at 24 h for the 
lowest fibre concentration from 6.47 to 12.01 mmol/L (p = 0.032), again, with a similar though not 
significant effect for both higher fibre concentrations. Rutin also caused an increase of butyric acid at 
24 h, from 16.86 to 27.20 mmol/L, (p = 0.020) and isovaleric acid at 24 h from 0.056 to 0.251 mmol/L, 
(p = 0.036). In contrast, in the presence of ISP, addition of rutin caused a decrease of acetic acid at 24 
h from 23.99 to 36.20 mmol/L (p = 0.034), increase of propionic acid from 16.26 to 11.63 mmol/L (p = 
0.044) and decrease of valeric acid at 24 h from 1.11 to 0.78 mmol/L (p = 0.026). Taken together, the 
data show that rutin slows down the fermentation of fermentable fibres and shifts the SCFA pattern 
towards production of propionic acid and branched short chain fatty acids. Full data on the effect of 
rutin on SCFA production of all fibres can be found in Supplementary Materials, Figure S2. 
4. Discussion 
This study aimed to determine if the catabolism of rutin to phenolic acids by the gut microbiota 
is affected by dietary fibre, We have shown that the type of dietary fibre alters the pattern of rutin 
catabolism in an in vitro gut fermentation model. Inulin, WB and RM significantly increased the 
concentrations of the main rutin metabolite, 3,4diOHPAA at 24 h. This may have important 
consequences on the bioavailability of 3,4diOHPAA and its biological activity. 3,4diOHPAA was 
previously shown to have a broad spectrum of potentially beneficial activities for mucosal health 
[15,26,43] and cardiometabolic outcomes [27]. The effect of fibre on phenolic acid production was 
confirmed using 13C isotopically labelled quercetin. Three possible mechanisms of action for this 
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interaction between the fibre and rutin catabolism are proposed: (i) sequestration by some fibres, (ii) 
changes in microbial communities driven by either substrate availability or antimicrobial action of 
released phenolics and (iii) saturation/competitive inhibition of microbial enzymes by fibres or their 
associated phenolic metabolites. 
Spiking with a standard compound mixture revealed selective sequestration of (poly)phenolics 
by some fibres. Quercetin recovery was significantly reduced in the presence of ISP and WB. The 
phenolic acids were selectively complexed by WB, those with two –OH substitutions of the benzene 
ring showed a higher affinity than those with one. Methylation reduced the affinity to WB (as seen 
for ferulic and caffeic acid) while reduction of the side chain increased the affinity (3,3,4diOHPPA vs. 
caffeic acid). Polyphenol binding capacity thus depends on their molecular weight, conformational 
mobility and flexibility, water solubility, and joint effects of these three factors [44]. Branched 
complex polysaccharides offer additional binding sites and together with the degree of the 
polyphenol B-ring substitution can play a major role in the extent of binding interactions. The high 
sequestration capacity of WB has been demonstrated for other organic compounds such as bile acids 
[45] and carcinogens [40]. Complex polysaccharides such as WB [46] and those that form viscous 
solutions (e.g., PEC) offer additional hydrophobic pockets sequestrating proanthocyanidins in 
comparison to filamentous or globular polysaccharides (xyloglucan or cellulose) [47]. 
It is well established that different fibres can selectively promote the populations and activities 
of individual bacterial species. and previous in vitro studies have suggested that the presence of 
glucose increases phenolic acid production from quercetin in fermentations [15,19], which is likely to 
be via its effect on the microbial catabolism or composition. We did not measure bacterial populations 
in this study but in studies by others, 16S rDNA profiling has previously that the static batch 
incubation model is useful to mimic colon microbial processes and is widely used to assess the impact 
of dietary factors on bacterial metabolism in a reproducible fashion for high throughput studies [48]. 
The abundance of lactobacilli increased in the presence of xylo-oligosaccharides and INU when 
compared to control without fibre or to the microcrystalline CEL, while resistant starch increased the 
Bacteroidaecae family. Moreover, in that study, these fibres decreased the relative abundance of the 
Lachnospiraceae family [48]. Inulin has a demonstrated effect on the growth of bifidobacteria both in 
vitro [49] and in vivo [50–52], highlighting the relevance of batch incubations for initial screening 
purposes. In another in vitro study, dietary fibres caused specific changes: resistant starch caused a 
6-13-fold increase in abundance of Ruminococcus bromii and increased the abundance of several 
species of bifidobacteria. PEC increased bifidobacteria and F. prausnitzii, while INU increased 
Anaerostipes hadrus and Coprococcus. eutactus; arabinoxylans, which presumably represent the highest 
fibre fraction of our WB sample increased the abundance of bifidobacteria, mainly of Bifidobacterum 
bifidum and B. longum up to 13-times [53]. 
Changes in microbial profile may play crucial role in phenolic catabolic profile. Microbial strains 
capable of complete catabolic breakdown of rutin to phloroglucinol, carbon dioxide, 3,4-dihydroxy-
benzaldehyde and 3,4diOHPAA include Butyrivibrio sp., lactobacilli and some other strains [54]. 
Clostridium perfringens, Bacteroides fragilis [55] Eubacterium ramulus and Flavonifractor plautii showed 
the ability to produce 3,4diOHPAA from quercetin [55]. Lactobacilli such as Lactobacillus brevis, L. 
fermentum and L. plantarum metabolize phenolic acids by decarboxylation and/or reduction, yielding 
dihydroderivatives or corresponding aldehydes [56]. L. fermentum was shown to reduce caffeic acid 
to dihydrocaffeic acid and similarly p-coumaric acid is metabolised by other Lactobacillus spp. [57,58]. 
Changes in abundance of these species and possibly many others, triggered by the presence of fibre, 
is likely to be responsible for the effect of dietary fibres on rutin catabolism seen in our study. The 
interplay between fibres, polyphenols and microbiota is very complex. Polyphenols are catabolised 
in the colon by specific microbial species, they n turn shape gut microbiota composition. This 
phenomenon has been recently reviewed [59,60]. 
Evidence from animal models has shown that pectin interacts with polyphenols in an as yet 
unknown way and that administration in combination (apple polyphenol fraction + fibre fraction) 
was more effective in preventing atherosclerosis in a mouse model than apple polyphenol fraction or 
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fibre fraction only [61] or that plasma levels of quercetin are higher in rats fed a rutin-pectin-diet than 
on a rutin-cellulose diet or basal diet with rutin [62,63]. 
Very few studies have investigated the fate of rutin or quercetin at physiological concentrations, 
[14,30] with other studies considering doses achievable only by supplements [15]. Our results differ 
from studies using higher doses of the parent compounds in that they report slower deglycosylation, 
[13] or observe 3,4diOHBA, 3,3OHPPA and 3,3,4diOHPPA and other metabolites alongside the four 
metabolites observed in the present study [13,15,64]. Studies with high doses also report higher 
recoveries of total metabolites to initial quercetin and longer lag time in decomposition of the parent 
compound, which may be due to saturation of microbial hydrolases and slower release of the 
aglycone or growth inhibition of selected intestinal bacterial species [65]. 
In our study, almost all initial rutin aglycone was degraded during the first 6 h, whereas in 
another study, most of the rutin (336 µg/mL) was still intact after 6 h fermentation [15]. This probably 
reflects the fact that in our study, the rutin dose was much lower, close to physiological intake. The 
fibres used here were themselves a good source of phenolic acids probably related to the non-
extractable polyphenols. Phenolic precursors of these metabolites are an inevitable component of cell 
wall structures, bridging and cross-linking structural carbohydrate polymers and may differ among 
plants [46]. 
Fibre intake in clinical trials is linked to the presence of phenolic metabolites in stool, such as 
ferulic acid, 3,4OH3MPPA and 3OHPPA [66]. These aromatic compounds can also derive from the 
phenylalanine, tyrosine and tryptophan degradation [67] forming in particular, PAA, 4OHPAA and 
indole-3-acetic acid [68]. These catabolic pathways exist in parallel and interact, suggesting a 
considerable role of the food matrix in polyphenol metabolism. For example, ferulic acid catabolism 
to 3OHPAA and 3,4OHPAA was reduced in vitro in subjects on a high-fat-high protein diet [69]. 
Our study showed which aromatic acids originated from protein catabolism, such as those 
occurring in blank-medium only and those present in vials with cellulose (mainly PAA, 3PPA and 
less 4OHPAA, 3,3OHPPA and 3,4OHPPA, those associated with the fibre and probably originating 
from plant-derived phenylpropanoids and amino acids (Figure 2). The presence of specific 
metabolites such as phenyllactic acid in INU fermentations is of interest and suggesting a specific 
precursor in the fibre. The 3-Phenyllactic acid is a potent antimicrobial agent used in the cheese 
industry and is produced by several strains of lactic acid bacteria, such as human colonic L. rhamnosus, 
from phenylalanine [70]. It promotes growth of some bacterial groups [71] and may act in quorum 
sensing [72,73]. The presence of this metabolite could contribute to the prebiotic effect of inulin. 
The presence of pectin led to production of 3,3OH4MPPA and 3,3OHPPA while WB was 
associated with high abundance of PAA and 3,3OHPPA, but also contained ferulic acid and 
3,4OH3MPPA (Table 1, Figure 2). This suggests different structural properties or different precursors. 
Interestingly, m-hydroxy dihydro-catabolites of rutin could be more resistant to further catabolism 
as microbial enzymes show preference towards faster removal of the hydroxyl or O-methoxy group 
in the para-position [74], explaining their higher proportion. 
The addition of rutin influences carbohydrate fermentation. Fermentation of fibres to SCFA is 
inhibited by rutin and the branched chain fatty acids increase in response to this, possibly originating 
from non-carbohydrate sources. Except for RM, rutin slightly increased pH in fermentations of all 
fibres including CEL, suggesting a slight effect on carbohydrate metabolism or microbiota profile 
even at the low, physiologically relevant concentrations used. Polyphenols have been shown to have 
potential to alter gut microecology by a prebiotic-like effect; selectively inhibiting the growth of 
certain bacterial species [65]. Isobutyric acid, for instance is produced by Odoribacter sp. [75] so such 
marked decrease may denote an effect on this or a similar microbial species. 
5. Conclusions 
In this study, dietary fibres showed differential interactions with dietary rutin which affected 
the pattern of phenolic acid and SCFA production. Wheat bran, pectin, psyllium, resistant 
maltodextrin, but not cellulose, were a rich source of phenolic acids producing a profile with some 
unique metabolites, characteristic for each fibre. Rutin at the physiological dose tested was 
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catabolised to four main phenolic acids. Addition of inulin, an analogue to 20 g bolus dietary intake 
increased the concentration of the main bioactive metabolite, 3,4diOHPAA in fermentations at 24 h 
2.3-fold and addition of wheat bran 2.5-fold. Moreover, the area under the curve of this metabolite 
tended to be higher in fermentations with fibre, suggesting higher bioaccessibility. Understanding 
these interactions is essential as fibre and polyphenols are often eaten together and the phenolic acids 
and SCFA produced may be important effectors for key health benefits. In vitro fermentation models 
have some limitations in closely modelling events in the human colon as they do not mimic 
absorption of bacterial products but they are useful for predicting microbial activity. The interactions 
between fibre, polyphenols and the gut microbiota need to be further studied in vivo. 
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sequestration properties, Figure S1: Inter-individual differences in the production of 3,4diOHPAA from rutin 
among donors and response to the presence of fibres, Figure S2: Effect of rutin on formation of short chain fatty 
acid from fibres (3 concentrations) in faecal incubations, Figure S3: Information sheet on the low polyphenol diet 
provided the stool donors. 
Author Contributions: Conceptualization, C.A.E. and E.C.; methodology, C.A.E., J.H. E.C. and D.J.M.; software, 
J.H..; validation, C.A.E.; formal analysis, T.P., W.M.; investigation, J.H., V.M., A.G. and M.H.; resources, C.A.E.; 
data curation, C.A.E.; writing—original draft preparation, J.H.; writing—review and editing, C.A.E, E.C. and 
D.J.M.; visualization, J.H.; supervision, C.A.E, T.P., W.M. D.J.M. and E.C.; project administration, C.A.E.; funding 
acquisition, C.A.E. All authors have read and agreed to the published version of the manuscript. 
Funding: This research was funded by the BBSRC (BB/M027724/1). 
Conflicts of Interest: The authors declare no conflict of interest. 
References 
1. Pérez-Jiménez, J.; Fezeu, L.; Touvier, M.; Arnault, N.; Manach, C.; Hercberg, S.; Galan, P.; Scalbert, A. 
Dietary intake of 337 polyphenols in French adults. Am. J. Clin. Nutr. 2011, 93, 1220–1228. 
doi:10.3945/ajcn.110.007096. 
2. Brat, P.; Georgé, S.; Bellamy, A.; Du Chaffaut, L.; Scalbert, A.; Mennen, L.; Arnault, N.; Amiot, M.J. Daily 
polyphenol intake in France from fruit and vegetables. J. Nutr. 2006, 136, 2368–2373. 
doi:10.1093/jn/136.9.2368. 
3. Williamson, G.; Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 
intervention studies. Am. J. Clin. Nutr. 2005, 81, 243S–255S. doi:10.1093/ajcn/81.1.243S. 
4. Neuhouser, M.L. Review: Dietary flavonoids and cancer risk: Evidence from human population studies. 
Nutr. Cancer 2004, 50, 1–7. doi:10.1207/s15327914nc5001_1. 
5. Ovaskainen, M.-L.; Törrönen, R.; Koponen, J.M.; Sinkko, H.; Hellström, J.; Reinivuo, H.; Mattila, P. Dietary 
intake and major food sources of polyphenols in Finnish adults. J. Nutr. 2008, 138, 562–566. 
doi:10.1093/jn/138.3.562. 
6. Zamora-Ros, R.; Andres-Lacueva, C.; Lamuela-Raventós, R.M.; Berenguer, T.; Jakszyn, P.; Barricarte, A.; 
Ardanaz, E.; Amiano, P.; Dorronsoro, M.; Larrañaga, N. Estimation of dietary sources and flavonoid intake 
in a Spanish adult population (EPIC-Spain). J. Am. Diet Assoc. 2010, 110, 390–398. 
doi:10.1016/j.jada.2009.11.024. 
7. Neveu, V.; Perez-Jiménez, J.; Vos, F.; Crespy, V.; du Chaffaut, L.; Mennen, L.; Knox, C.; Eisner, R.; Cruz, R.; 
Wishart, D.; et al. Phenol-Explorer: An online comprehensive database on polyphenol contents in foods. 
Database 2010. doi:10.1093/database/bap024. 
8. Wada, L.; Ou, B. Antioxidant activity and phenolic content of Oregon caneberries. J. Agric. Food Chem. 2002, 
50, 3495–3500. doi:10.1021/jf011405l. 
9. Hui, C.; Qi, X.; Qianyong, Z.; Xiaoli, P.; Jundong, Z.; Mantian, M. Flavonoids, flavonoid subclasses and 
breast cancer risk: A meta-analysis of epidemiologic studies. PLoS ONE 2013, 8, e54318. 
doi:10.1371/journal.pone.0054318. 
Nutrients 2020, 12, 1577 14 of 17 
 
10. Edwards, R.L.; Lyon, T.; Litwin, S.E.; Rabovsky, A.; Symons, J.D.; Jalili, T. Quercetin reduces blood pressure 
in hypertensive subjects. J. Nutr. 2007, 137, 2405–2411. doi:10.1093/jn/137.11.2405. 
11. Wang, X.; Ouyang, Y.Y.; Liu, J.; Zhao, G. Flavonoid intake and risk of CVD: A systematic review and meta-
analysis of prospective cohort studies. Br. J. Nutr. 2014, 111, 1–11. doi:10.1017/S000711451300278X. 
12. Menezes, R.; Rodriguez-Mateos, A.; Kaltsatou, A.; González-Sarrías, A.; Greyling, A.; Giannaki, C.; Andres-
Lacueva, C.; Milenkovic, D.; Gibney, E.; Dumont, J. Impact of flavonols on cardiometabolic biomarkers: A 
meta-analysis of randomized controlled human trials to explore the role of inter-individual variability. 
Nutrients 2017, 9, 117. doi:10.3390/nu9020117. 
13. Rechner, A.R.; Smith, M.A.; Kuhnle, G.; Gibson, G.R.; Debnam, E.S.; Srai, S.K.S.; Moore, K.P.; Rice-Evans, 
C.A. Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation 
products. Free Radic. Biol. Med. 2004, 36, 212–225. doi:10.1016/j.freeradbiomed.2003.09.022. 
14. Aura, A.-M.; O’leary, K.; Williamson, G.; Ojala, M.; Bailey, M.; Puupponen-Pimiä, R.; Nuutila, A.; Oksman-
Caldentey, K.-M.; Poutanen, K. Quercetin derivatives are deconjugated and converted to 
hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. J. Agric. Food Chem. 2002, 50, 
1725–1730. doi:10.1021/jf0108056. 
15. Jaganath, I.B.; Mullen, W.; Lean, M.E.; Edwards, C.A.; Crozier, A. In vitro catabolism of rutin by human 
fecal bacteria and the antioxidant capacity of its catabolites. Free Radic. Biol. Med. 2009, 47, 1180–1189. 
doi:10.1016/j.freeradbiomed.2009.07.031. 
16. Manach, C.; Morand, C.; Demigné, C.; Texier, O.; Régérat, F.; Rémésy, C. Bioavailability of rutin and 
quercetin in rats. FEBS Lett. 1997, 409, 12–16. doi:10.1016/S0014-5793(97)00467-5. 
17. Baba, S.; Furuta, T.; Fujioka, M.; Goromaru, T. Studies on drug metabolism by use of isotopes XXVII: 
Urinary metabolites of rutin in rats and the role of intestinal microflora in the metabolism of rutin. J. Pharm. 
Sci. 1983, 72, 1155–1158. doi:10.1002/jps.2600721011. 
18. Griffiths, L.; Barrow, A. Metabolism of flavonoid compounds in germ-free rats. Biochem. J. 1972, 130, 1161–
1162. doi:10.1042/bj1301161. 
19. Jaganath, I.B.; Jaganath, I.B.; Mullen, W.; Edwards, C.A.; Crozier, A. The relative contribution of the small 
and large intestine to the absorption and metabolism of rutin in man. Free Radic. Res. 2006, 40, 1035–1046. 
doi:10.1080/10715760600771400. 
20. Hollman, P.C.; Gaag, M.V.; Mengelers, M.J.; Van Trijp, J.M.; De Vries, J.H.; Katan, M.B. Absorption and 
disposition kinetics of the dietary antioxidant quercetin in man. Free Radic. Biol. Med. 1996, 21, 703–707. 
doi:10.1016/0891-5849(96)00129-3. 
21. Alkhaldy, A.; Edwards, C.A.; Combet, E. The urinary phenolic acid profile varies between younger and 
older adults after a polyphenol-rich meal despite limited differences in in vitro colonic catabolism. Eur. J. 
Nutr. 2019, 58, 1095–1111. doi:10.1007/s00394-018-1625-1. 
22. Alkhaldy, A.; Edwards, A.C.; Combet, E. Effect of ethnicity and a fermentable fibre on the in vitro colonic 
metabolism of polyphenols. Proc. Nutr. Soc. 2012, 71, E61. doi:10.1017/S0029665112001188. 
23. Vlassopoulos, A.; Lean, M.E.J.; Combet, E. Role of oxidative stress in physiological albumin glycation: A 
neglected interaction. Free Radic. Biol. Med. 2013, 60, 318–324. doi:10.1016/j.freeradbiomed.2013.03.010. 
24. Tang, Y.; Nakashima, S.; Saiki, S.; Myoi, Y.; Abe, N.; Kuwazuru, S.; Zhu, B.; Ashida, H.; Murata, Y.; 
Nakamura, Y. 3, 4-Dihydroxyphenylacetic acid is a predominant biologically-active catabolite of quercetin 
glycosides. Food Res. Int. 2016, 89, 716–723. doi:10.1016/j.foodres.2016.09.034. 
25. Rechner, A.R.; Kroner, C. Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet 
function. Thromb. Res. 2005, 116, 327–334. doi:10.1016/j.thromres.2005.01.002. 
26. Monagas, M.; Khan, N.; Andrés-Lacueva, C.; Urpí-Sardá, M.; Vázquez-Agell, M.; Lamuela-Raventós, R.M.; 
Estruch, R. Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-
stimulated cytokine secretion by human peripheral blood mononuclear cells. Br. J. Nutr. 2009, 102, 201–206. 
doi:10.1017/S0007114508162110. 
27. Pashikanti, S.; de Alba, D.R.; Boissonneault, G.A.; Cervantes-Laurean, D. Rutin metabolites: Novel 
inhibitors of nonoxidative advanced glycation end products. Free Radic. Biol. Med. 2010, 48, 656–663. 
doi:10.1016/j.freeradbiomed.2009.11.019. 
28. Sánchez-Patán, F.; Cueva, C.; Monagas, M.; Walton, G.E.; Gibson, G.R.; Martín-Álvarez, P.J.; Moreno-
Arribas, M.V.; Bartolomé, B. Gut microbial catabolism of grape seed flavan-3-ols by human faecal 
microbiota. Targetted analysis of precursor compounds, intermediate metabolites and end-products. Food 
Chem. 2012, 131, 337–347. doi:10.1016/j.foodchem.2011.08.011. 
Nutrients 2020, 12, 1577 15 of 17 
 
29. Jarosova, V.; Vesely, O.; Marsik, P.; Jaimes, J.D.; Smejkal, K.; Kloucek, P.; Havlik, J. Metabolism of 
stilbenoids by human faecal microbiota. Molecules 2019, 24, 1155. doi:10.3390/molecules24061155. 
30. Parkar, S.G.; Trower, T.M.; Stevenson, D.E. Fecal microbial metabolism of polyphenols and its effects on 
human gut microbiota. Anaerobe 2013, 23, 12–19. doi:10.1016/j.anaerobe.2013.07.009. 
31. Mansoorian, B.; Combet, E.; Alkhaldy, A.; Garcia, A.L.; Edwards, C.A. Impact of fermentable fibres on the 
colonic microbiota metabolism of dietary polyphenols rutin and quercetin. Int. J. Environ. Res. Pubic. Health 
2019, 16, 292. doi:10.3390/ijerph16020292. 
32. Koziolek, M.; Grimm, M.; Becker, D.; Iordanov, V.; Zou, H.; Shimizu, J.; Wanke, C.; Garbacz, G.; Weitschies, 
W. Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the 
Intellicap® system. J. Pharm. Sci. 2015, 104, 2855–2863. doi:10.1002/jps.24274. 
33. Walker, A.W.; Duncan, S.H.; Leitch, E.C.M.; Child, M.W.; Flint, H.J. pH and peptide supply can radically 
alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human 
colon. Appl. Environ. Microbiol. 2005, 71, 3692–3700. doi:10.1128/AEM.71.7.3692-3700.2005. 
34. Crittenden, R.; Karppinen, S.; Ojanen, S.; Tenkanen, M.; Fagerström, R.; Mättö, J.; Saarela, M.; Mattila-
Sandholm, T.; Poutanen, K. In vitro fermentation of cereal dietary fibre carbohydrates by probiotic and 
intestinal bacteria. J. Sci. Food Agric. 2002, 82, 781–789. doi:10.1002/jsfa.1095. 
35. Brownlee, I.A. The physiological roles of dietary fibre. Food Hydrocoll. 2011, 25, 238–250. 
doi:10.1016/j.foodhyd.2009.11.013. 
36. Bazzocco, S.; Mattila, I.; Guyot, S.; Renard, C.M.; Aura, A.-M. Factors affecting the conversion of apple 
polyphenols to phenolic acids and fruit matrix to short-chain fatty acids by human faecal microbiota in 
vitro. Eur. J. Nutr. 2008, 47, 442–452. doi:10.1007/s00394-008-0747-2. 
37. Khossousi, A.; Binns, C.; Dhaliwal, S.; Pal, S. The acute effects of psyllium on postprandial lipaemia and 
thermogenesis in overweight and obese men. Br. J. Nutr. 2008, 99, 1068–1075. 
doi:10.1017/S0007114507864804. 
38. Harris, H.C.; Edwards, C.A.; Morrison, D.J. Impact of glycosidic bond configuration on short chain fatty 
acid production from model fermentable carbohydrates by the human gut microbiota. Nutrients 2017, 9, 26. 
doi:10.3390/nu9010026. 
39. Ladas, S.; Isaacs, P.; Murphy, G.; Sladen, G. Fasting and postprandial ileal function in adapted ileostomates 
and normal subjects. Gut 1986, 27, 906–912. doi:10.1136/gut.27.8.906. 
40. Ferguson, L.; Harris, P. Protection against cancer by wheat bran: Role of dietary fibre and phytochemicals. 
Eur. J. Cancer Prev. 1999, 8, 17–26. doi:10.1097/00008469-199902000-00003. 
41. Combet, E.; Lean, M.E.; Boyle, J.G.; Crozier, A.; Davidson, D.F. Dietary flavonols contribute to false-positive 
elevation of homovanillic acid, a marker of catecholamine-secreting tumors. Clin. Chim. Acta 2011, 412, 165–
169. doi:10.1016/j.cca.2010.09.037. 
42. Grün, C.H.; van Dorsten, F.A.; Jacobs, D.M.; Le Belleguic, M.; van Velzen, E.J.; Bingham, M.O.; Janssen, H.-
G.; van Duynhoven, J.P. GC–MS methods for metabolic profiling of microbial fermentation products of 
dietary polyphenols in human and in vitro intervention studies. J. Chromatogr. B 2008, 871, 212–219. 
doi:10.1016/j.jchromb.2008.04.039. 
43. Kim, D.-H.; Jung, E.-A.; Sohng, I.-S.; Han, J.-A.; Kim, T.-H.; Han, M.J. Intestinal bacterial metabolism of 
flavonoids and its relation to some biological activities. Arch. Pharm. Res. 1998, 21, 17–23. 
doi:10.1007/BF03216747. 
44. Le Bourvellec, C.; Renard, C. Interactions between polyphenols and macromolecules: Quantification 
methods and mechanisms. Crit. Rev. Food Sci. Nutr. 2012, 52, 213–248. doi:10.1080/10408398.2010.499808. 
45. Vahouny, G.V.; Tombes, R.; Cassidy, M.M.; Kritchevsky, D.; Gallo, L.L. Dietary fibers: V. Binding of bile 
salts, phospholipids and cholesterol from mixed micelles by bile acid sequestrants and dietary fibers. Lipids 
1980, 15, 1012–1018. doi:10.1007/BF02534316. 
46. Carpita, N.C.; Gibeaut, D.M. Structural models of primary cell walls in flowering plants: Consistency of 
molecular structure with the physical properties of the walls during growth. Plant J. 1993, 3, 1–30. 
doi:10.1111/j.1365-313X.1993.tb00007.x. 
47. Le Bourvellec, C.; Bouchet, B.; Renard, C. Non-covalent interaction between procyanidins and apple cell 
wall material. Part III: Study on model polysaccharides. Biophys. Acta Gen. Subj. 2005, 1725, 10–18. 
doi:10.1016/j.bbagen.2005.06.004. 
Nutrients 2020, 12, 1577 16 of 17 
 
48. Tsitko, I.; Wiik-Miettinen, F.; Mattila, O.; Rosa-Sibakov, N.; Seppänen-Laakso, T.; Maukonen, J.; Nordlund, 
E.; Saarela, M. A small in vitro fermentation model for screening the gut microbiota effects of different fiber 
preparations. Int. J. Mol. Sci. 2019, 20, 1925. doi:10.3390/ijms20081925. 
49. Roberfroid, M.B.; Van Loo, J.A.; Gibson, G.R. The bifidogenic nature of chicory inulin and its hydrolysis 
products. J. Nutr. 1998, 128, 11–19. doi:10.1093/jn/128.1.11. 
50. Salazar, N.; Dewulf, E.M.; Neyrinck, A.M.; Bindels, L.B.; Cani, P.D.; Mahillon, J.; de Vos, W.M.; Thissen, 
J.P.; Gueimonde, M.; de Los Reyes-Gavilán, C.G.; et al. Inulin-type fructans modulate intestinal 
Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clin. Nutr. 
2015, 34, 501–507. doi:10.1016/j.clnu.2014.06.001. 
51. Lohner, S.; Jakobik, V.; Mihályi, K.; Soldi, S.; Vasileiadis, S.; Theis, S.; Sailer, M.; Sieland, C.; Berényi, K.; 
Boehm, G.; et al. Inulin-type fructan supplementation of 3-to 6-year-old children is associated with higher 
fecal Bifidobacterium concentrations and fewer febrile episodes requiring medical attention. J. Nutr. 2018, 
148, 1300–1308. doi:10.1093/jn/nxy120. 
52. Reimer, R.A.; Soto-Vaca, A.; Nicolucci, A.C.; Mayengbam, S.; Park, H.; Madsen, K.L.; Menon, R.; Vaughan, 
E.E. Effect of chicory inulin-type fructan–containing snack bars on the human gut microbiota in low dietary 
fiber consumers in a randomized crossover trial. Am. J. Clin. Nutr. 2020. doi:10.1093/ajcn/nqaa074. 
53. Reichardt, N.; Vollmer, M.; Holtrop, G.; Farquharson, F.M.; Wefers, D.; Bunzel, M.; Duncan, S.H.; Drew, 
J.E.; Williams, L.M.; Milligan, G.; et al. Specific substrate-driven changes in human faecal microbiota 
composition contrast with functional redundancy in short-chain fatty acid production. ISME J. 2018, 12, 
610–622. doi:10.1038/ismej.2017.196. 
54. Blaut, M.; Schoefer, L.; Braune, A. Transformation of flavonoids by intestinal microorganisms. Int. J. Vitam. 
Nutr. Res. 2003, 73, 79–87. doi:10.1024/0300-9831.73.2.79. 
55. Ulbrich, K.; Reichardt, N.; Braune, A.; Kroh, L.W.; Blaut, M.; Rohn, S. The microbial degradation of onion 
flavonol glucosides and their roasting products by the human gut bacteria Eubacterium ramulus and 
Flavonifractor plautii. Food Res. Int. 2015, 67, 349–355. doi:10.1016/j.foodres.2014.11.051. 
56. Sánchez-Maldonado, A.F.; Schieber, A.; Gänzle, M.G. Structure–function relationships of the antibacterial 
activity of phenolic acids and their metabolism by lactic acid bacteria. J. Appl. Microbiol. 2011, 111, 1176–
1184. doi:10.1111/j.1365-2672.2011.05141.x. 
57. Van Beek, S.; Priest, F.G. Decarboxylation of substituted cinnamic acids by lactic acid bacteria isolated 
during malt whisky fermentation. Appl. Environ. Microbiol. 2000, 66, 5322–5328. 
doi:10.1128/AEM.66.12.5322-5328.2000. 
58. Rodriguez, H.; Landete, J.M.; Curiel, J.A.; de Las Rivas, B.; Mancheño, J.M.; Muñoz, R. Characterization of 
the p-coumaric acid decarboxylase from Lactobacillus plantarum CECT 748T. J. Agric. Food Chem. 2008, 56, 
3068–3072. doi:10.1021/jf703779s. 
59. Kumar Singh, A.; Cabral, C.; Kumar, R.; Ganguly, R.; Kumar Rana, H.; Gupta, A.; Rosaria Lauro, M.; 
Carbone, C.; Reis, F.; Pandey, A.K. Beneficial effects of dietary polyphenols on gut microbiota and strategies 
to improve delivery efficiency. Nutrients 2019, 11, 2216. doi:10.3390/nu11092216. 
60. Chen, T.; Yang, C.S. Biological fates of tea polyphenols and their interactions with microbiota in the 
gastrointestinal tract: Implications on health effects. Crit. Rev. Food Sci. Nutr. 2019, 1–19. 
doi:10.1080/10408398.2019.1654430. 
61. Auclair, S.; Silberberg, M.; Gueux, E.; Morand, C.; Mazur, A.; Milenkovic, D.; Scalbert, A. Apple 
polyphenols and fibers attenuate atherosclerosis in apolipoprotein E-deficient mice. J. Agric. Food Chem. 
2008, 56, 5558–5563. doi:10.1021/jf800419s. 
62. Tamura, M.; Nakagawa, H.; Tsushida, T.; Hirayama, K.; Itoh, K. Effect of pectin enhancement on plasma 
quercetin and fecal flora in rutin-supplemented mice. J. Food Sci. 2007, 72, S648–S651. doi:10.1111/j.1750-
3841.2007.00557.x. 
63. Nishijima, T.; Iwai, K.; Saito, Y.; Takida, Y.; Matsue, H. Chronic ingestion of apple pectin can enhance the 
absorption of quercetin. J. Agric. Food Chem. 2009, 57, 2583–2587. doi:10.1021/jf803547h. 
64. Justesen, U.; Arrigoni, E. Electrospray ionisation mass spectrometric study of degradation products of 
quercetin, quercetin-3-glucoside and quercetin-3-rhamnoglucoside, produced by in vitro fermentation 
with human faecal flora. Rapid Commun. Mass Spectrom. 2001, 15, 477–483. doi:10.1002/rcm.250. 
65. Parkar, S.G.; Stevenson, D.E.; Skinner, M.A. The potential influence of fruit polyphenols on colonic 
microflora and human gut health. Int. J. Food Microbiol. 2008, 124, 295–298. 
doi:10.1016/j.ijfoodmicro.2008.03.017. 
Nutrients 2020, 12, 1577 17 of 17 
 
66. Russell, W.R.; Gratz, S.W.; Duncan, S.H.; Holtrop, G.; Ince, J.; Scobbie, L.; Duncan, G.; Johnstone, A.M.; 
Lobley, G.E.; Wallace, R.J. High-protein, reduced-carbohydrate weight-loss diets promote metabolite 
profiles likely to be detrimental to colonic health. Am. J. Clin. Nutr. 2011, 93, 1062–1072. doi:1062-1072, 
10.3945/ajcn.110.002188. 
67. Macfarlane, G.T.; Macfarlane, S. Bacteria, colonic fermentation, and gastrointestinal health. J. AOAC Int. 
2012, 95, 50–60. doi:10.5740/jaoacint.sge_macfarlane. 
68. Russell, W.R.; Duncan, S.H.; Scobbie, L.; Duncan, G.; Cantlay, L.; Calder, A.G.; Anderson, S.E.; Flint, H.J. 
Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of 
protein. Mol. Nutr. Food Res. 2013, 57, 523–535. doi:10.1002/mnfr.201200594. 
69. Russell, W.R.; Hoyles, L.; Flint, H.J.; Dumas, M.-E. Colonic bacterial metabolites and human health. Curr. 
Opin. Microbiol. 2013, 16, 246–254. doi:10.1016/j.mib.2013.07.002. 
70. Valerio, F.; Lavermicocca, P.; Pascale, M.; Visconti, A. Production of phenyllactic acid by lactic acid bacteria: 
An approach to the selection of strains contributing to food quality and preservation. FEMS Microbiol. Lett. 
2004, 233, 289–295. doi:10.1111/j.1574-6968.2004.tb09494.x. 
71. Kaplan, H.; Hutkins, R.W. Fermentation of fructooligosaccharides by lactic acid bacteria and bifidobacteria. 
Appl. Environ. Microbiol. 2000, 66, 2682–2684. doi:10.1128/AEM.66.6.2682-2684.2000. 
72. Chifiriuc, M.C.; Veronica, L.; Dracea, O.; Ditu, L.-M.; Smarandache, D.; Bucur, M.; Larion, C.; Ramona, C.; 
Sasarman, E. Drastic attenuation of Pseudomonas aeruginosa pathogenicity in a holoxenic mouse 
experimental model induced by subinhibitory concentrations of phenyllactic acid (PLA). Int. J. Mol. Sci. 
2007, 8, 583–592. doi:10.3390/i8070583. 
73. Chifiriuc, M.-C.; Diţu, L.; Banu, O.; Bleotu, C.; Drăcea, O.; Bucur, M.; Larion, C.; Israil, A.M.; Lazăr, V. 
Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in 
Staphylococcus aureus and Pseudomonas aeruginosa clinical strains. Roum. Arch. Microbiol. Immunol. 2009, 
68, 27–33. 
74. Williamson, G.; Clifford, M.N. Colonic metabolites of berry polyphenols: The missing link to biological 
activity? Br. J. Nutr. 2010, 104, S48–S66. doi:10.1017/S0007114510003946. 
75. Granado-Serrano, A.B.; Martín-Garí, M.; Sánchez, V.; Solans, M.R.; Berdún, R.; Ludwig, I.A.; Rubió, L.; 
Vilaprinyó, E.; Portero-Otín, M.; Serrano, J.C.E. Faecal bacterial and short-chain fatty acids signature in 
hypercholesterolemia. Sci. Rep. 2019, 9, 1772. doi:10.1038/s41598-019-38874-3. 
 
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
 
 
